"Finding the right FIT"

Rural patient preferences for fecal immunochemical test (FIT) characteristics

Robyn Pham, Suzanne Cross, Bianca Fernandez, Kathryn Corson, Kristen Dillon, Coco Yackley, Melinda Davis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, yet 1 in 3 Americans have never been screened for CRC. Annual screening using fecal immunochemical tests (FITs) is often a preferred modality in populations experiencing CRC screening disparities. Although multiple studies evaluate the clinical effectiveness of FITs, few studies assess patient preferences toward kit characteristics. We conducted this community-led study to assess patient preferences for FIT characteristics and to use study findings in concert with clinical effectiveness data to inform regional FIT selection. Methods: We collaborated with local health system leaders to identify FITs and recruit age eligible (50 to 75 years), English or Spanish speaking community members. Participants completed up to 6 FITs and associated questionnaires and were invited to participate in a follow-up focus group. We used a sequential explanatory mixed-methods design to assess participant preferences and rank FIT kits. First, we used quantitative data from user testing to measure acceptability, ease of completion, and specimen adequacy through a descriptive analysis of 1) fixed response questionnaire items on participant attitudes toward and experiences with FIT kits, and 2) a clinical assessment of adherence to directions regarding collection, packaging, and return of specimens. Second, we analyzed qualitative data from focus groups to refine FIT rankings and gain deeper insight into the pros and cons associated with each tested kit. Findings: Seventy-six FITs were completed by 18 participants (Range, 3 to 6 kits per participant). Over half (56%, n = 10) of the participants were Hispanic and 50% were female (n = 9). Thirteen participants attended 1 of 3 focus groups. Participants preferred FITs that were single sample, used a probe and vial for sample collection, and had simple, large-font instructions with colorful pictures. Participants reported challenges using paper to catch samples, had difficulty labeling tests, and emphasized the importance of having care team members provide verbal instructions on test completion and follow- up support for patients with abnormal results. FIT rankings from most to least preferred were OCLight, Hemosure iFOB Test, InSure FIT, QuickVue, OneStep+, and Hemoccult ICT. Conclusions: FIT characteristics influenced patient's perceptions of test acceptability and feasibility. Health system leaders, payers, and clinicians should select FITs that are both clinically effective and incorporate patient preferred test characteristics. Consideration of patient preferences may facilitate FIT return, especially in populations at higher risk for experiencing CRC screening disparities.

Original languageEnglish (US)
Pages (from-to)632-644
Number of pages13
JournalJournal of the American Board of Family Medicine
Volume30
Issue number5
DOIs
StatePublished - Sep 1 2017

Fingerprint

Patient Preference
Colorectal Neoplasms
Focus Groups
Early Detection of Cancer
Health
Product Packaging
Hispanic Americans
Cause of Death
Population
Neoplasms
Surveys and Questionnaires

Keywords

  • Colorectal Neoplasms
  • Early Detection of Cancer
  • Occult Blood
  • Patient Preference
  • Treatment Outcome

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

"Finding the right FIT" : Rural patient preferences for fecal immunochemical test (FIT) characteristics. / Pham, Robyn; Cross, Suzanne; Fernandez, Bianca; Corson, Kathryn; Dillon, Kristen; Yackley, Coco; Davis, Melinda.

In: Journal of the American Board of Family Medicine, Vol. 30, No. 5, 01.09.2017, p. 632-644.

Research output: Contribution to journalArticle

Pham, Robyn ; Cross, Suzanne ; Fernandez, Bianca ; Corson, Kathryn ; Dillon, Kristen ; Yackley, Coco ; Davis, Melinda. / "Finding the right FIT" : Rural patient preferences for fecal immunochemical test (FIT) characteristics. In: Journal of the American Board of Family Medicine. 2017 ; Vol. 30, No. 5. pp. 632-644.
@article{8dfc584aba0f46568c1d9b2a6a439b97,
title = "{"}Finding the right FIT{"}: Rural patient preferences for fecal immunochemical test (FIT) characteristics",
abstract = "Purpose: Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, yet 1 in 3 Americans have never been screened for CRC. Annual screening using fecal immunochemical tests (FITs) is often a preferred modality in populations experiencing CRC screening disparities. Although multiple studies evaluate the clinical effectiveness of FITs, few studies assess patient preferences toward kit characteristics. We conducted this community-led study to assess patient preferences for FIT characteristics and to use study findings in concert with clinical effectiveness data to inform regional FIT selection. Methods: We collaborated with local health system leaders to identify FITs and recruit age eligible (50 to 75 years), English or Spanish speaking community members. Participants completed up to 6 FITs and associated questionnaires and were invited to participate in a follow-up focus group. We used a sequential explanatory mixed-methods design to assess participant preferences and rank FIT kits. First, we used quantitative data from user testing to measure acceptability, ease of completion, and specimen adequacy through a descriptive analysis of 1) fixed response questionnaire items on participant attitudes toward and experiences with FIT kits, and 2) a clinical assessment of adherence to directions regarding collection, packaging, and return of specimens. Second, we analyzed qualitative data from focus groups to refine FIT rankings and gain deeper insight into the pros and cons associated with each tested kit. Findings: Seventy-six FITs were completed by 18 participants (Range, 3 to 6 kits per participant). Over half (56{\%}, n = 10) of the participants were Hispanic and 50{\%} were female (n = 9). Thirteen participants attended 1 of 3 focus groups. Participants preferred FITs that were single sample, used a probe and vial for sample collection, and had simple, large-font instructions with colorful pictures. Participants reported challenges using paper to catch samples, had difficulty labeling tests, and emphasized the importance of having care team members provide verbal instructions on test completion and follow- up support for patients with abnormal results. FIT rankings from most to least preferred were OCLight, Hemosure iFOB Test, InSure FIT, QuickVue, OneStep+, and Hemoccult ICT. Conclusions: FIT characteristics influenced patient's perceptions of test acceptability and feasibility. Health system leaders, payers, and clinicians should select FITs that are both clinically effective and incorporate patient preferred test characteristics. Consideration of patient preferences may facilitate FIT return, especially in populations at higher risk for experiencing CRC screening disparities.",
keywords = "Colorectal Neoplasms, Early Detection of Cancer, Occult Blood, Patient Preference, Treatment Outcome",
author = "Robyn Pham and Suzanne Cross and Bianca Fernandez and Kathryn Corson and Kristen Dillon and Coco Yackley and Melinda Davis",
year = "2017",
month = "9",
day = "1",
doi = "10.3122/jabfm.2017.05.170151",
language = "English (US)",
volume = "30",
pages = "632--644",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "5",

}

TY - JOUR

T1 - "Finding the right FIT"

T2 - Rural patient preferences for fecal immunochemical test (FIT) characteristics

AU - Pham, Robyn

AU - Cross, Suzanne

AU - Fernandez, Bianca

AU - Corson, Kathryn

AU - Dillon, Kristen

AU - Yackley, Coco

AU - Davis, Melinda

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Purpose: Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, yet 1 in 3 Americans have never been screened for CRC. Annual screening using fecal immunochemical tests (FITs) is often a preferred modality in populations experiencing CRC screening disparities. Although multiple studies evaluate the clinical effectiveness of FITs, few studies assess patient preferences toward kit characteristics. We conducted this community-led study to assess patient preferences for FIT characteristics and to use study findings in concert with clinical effectiveness data to inform regional FIT selection. Methods: We collaborated with local health system leaders to identify FITs and recruit age eligible (50 to 75 years), English or Spanish speaking community members. Participants completed up to 6 FITs and associated questionnaires and were invited to participate in a follow-up focus group. We used a sequential explanatory mixed-methods design to assess participant preferences and rank FIT kits. First, we used quantitative data from user testing to measure acceptability, ease of completion, and specimen adequacy through a descriptive analysis of 1) fixed response questionnaire items on participant attitudes toward and experiences with FIT kits, and 2) a clinical assessment of adherence to directions regarding collection, packaging, and return of specimens. Second, we analyzed qualitative data from focus groups to refine FIT rankings and gain deeper insight into the pros and cons associated with each tested kit. Findings: Seventy-six FITs were completed by 18 participants (Range, 3 to 6 kits per participant). Over half (56%, n = 10) of the participants were Hispanic and 50% were female (n = 9). Thirteen participants attended 1 of 3 focus groups. Participants preferred FITs that were single sample, used a probe and vial for sample collection, and had simple, large-font instructions with colorful pictures. Participants reported challenges using paper to catch samples, had difficulty labeling tests, and emphasized the importance of having care team members provide verbal instructions on test completion and follow- up support for patients with abnormal results. FIT rankings from most to least preferred were OCLight, Hemosure iFOB Test, InSure FIT, QuickVue, OneStep+, and Hemoccult ICT. Conclusions: FIT characteristics influenced patient's perceptions of test acceptability and feasibility. Health system leaders, payers, and clinicians should select FITs that are both clinically effective and incorporate patient preferred test characteristics. Consideration of patient preferences may facilitate FIT return, especially in populations at higher risk for experiencing CRC screening disparities.

AB - Purpose: Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, yet 1 in 3 Americans have never been screened for CRC. Annual screening using fecal immunochemical tests (FITs) is often a preferred modality in populations experiencing CRC screening disparities. Although multiple studies evaluate the clinical effectiveness of FITs, few studies assess patient preferences toward kit characteristics. We conducted this community-led study to assess patient preferences for FIT characteristics and to use study findings in concert with clinical effectiveness data to inform regional FIT selection. Methods: We collaborated with local health system leaders to identify FITs and recruit age eligible (50 to 75 years), English or Spanish speaking community members. Participants completed up to 6 FITs and associated questionnaires and were invited to participate in a follow-up focus group. We used a sequential explanatory mixed-methods design to assess participant preferences and rank FIT kits. First, we used quantitative data from user testing to measure acceptability, ease of completion, and specimen adequacy through a descriptive analysis of 1) fixed response questionnaire items on participant attitudes toward and experiences with FIT kits, and 2) a clinical assessment of adherence to directions regarding collection, packaging, and return of specimens. Second, we analyzed qualitative data from focus groups to refine FIT rankings and gain deeper insight into the pros and cons associated with each tested kit. Findings: Seventy-six FITs were completed by 18 participants (Range, 3 to 6 kits per participant). Over half (56%, n = 10) of the participants were Hispanic and 50% were female (n = 9). Thirteen participants attended 1 of 3 focus groups. Participants preferred FITs that were single sample, used a probe and vial for sample collection, and had simple, large-font instructions with colorful pictures. Participants reported challenges using paper to catch samples, had difficulty labeling tests, and emphasized the importance of having care team members provide verbal instructions on test completion and follow- up support for patients with abnormal results. FIT rankings from most to least preferred were OCLight, Hemosure iFOB Test, InSure FIT, QuickVue, OneStep+, and Hemoccult ICT. Conclusions: FIT characteristics influenced patient's perceptions of test acceptability and feasibility. Health system leaders, payers, and clinicians should select FITs that are both clinically effective and incorporate patient preferred test characteristics. Consideration of patient preferences may facilitate FIT return, especially in populations at higher risk for experiencing CRC screening disparities.

KW - Colorectal Neoplasms

KW - Early Detection of Cancer

KW - Occult Blood

KW - Patient Preference

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85029722871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029722871&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2017.05.170151

DO - 10.3122/jabfm.2017.05.170151

M3 - Article

VL - 30

SP - 632

EP - 644

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 5

ER -